Thoracic Neoplasms  >>  Tepezza (teprotumumab-trbw)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tepezza (teprotumumab-trbw) / Roche, Amgen
NCT00773383 / 2008-001762-85: A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.

Terminated
2
35
US, Canada, Europe
RG1507, erlotinib [Tarceva]
Hoffmann-La Roche
Non-Small Cell Lung Cancer
02/10
02/10

Download Options